Mechanisms for inducible control of angiotensinogen gene transcription

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 465-475

  Brasier, Allan R ^a,b   Li, Junyi ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b 3142 Medical Research Building ^*  (United States)

Author keywords

angiotensinogen; nuclear factor IL6; nuclear factor B

Indexed keywords

ANGIOTENSIN; BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; GENETIC TRANSCRIPTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029979243     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.465     Document Type: Conference Paper

References (108)

1. Tewksbury DA. Angiotensinogen: biochemistry and molecular biology. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press Publishers; 1990:1197-1216.
2. Cassio D, Weiss MC, Ott M-O, Sala-Trepat JM, Fries J, Erdos T. Expression of the albumin gene in rat hepatoma cells and their dedifferentiated variants. Cell. 1981;27:351-358.
3. Coezy E, Bouhnik J, Clauser E, Pinet F, Philippe M, Menard J, Corvol P. Effects of glucocorticoids and antiglucocorticoids on angiotensinogen production by hepatoma cells in culture. In Vitro. 1984;20:528-534.
4. Birch H, Schreiber G. Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem. 1986;261:8077-8080.
5. Reid IA, Morris BJ, Ganong WG. The renin-angiotensin system. Annu Rev Physiol. 1978;40:377-410.
6. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313-370.
7. Krakoff LR. Measurement of plasma-renin substrate by radioimmunoassay of angiotensin, I: concentration in syndromes associated with steroid excess. J Clin Endocrinol Metab. 1973;37: 110-117.
8. Walker WG, Whelton PK, Saito H, Russel RP, Hermann J. Relation between blood pressure and renin, renin substrate, Ang II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1:287-291.
9. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
10. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
11. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR (mRen-2) 27 rat. J Hypertens. 1995;25:1014-1020.
12. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269:31334-31337.
13. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11:821-827.
14. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, Yokota Y, Iwai M, Tanabe Y, Masu M, Hata J, Iwao H. Generation of transgenic mice with elevated blood pressure by introduction of rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1990;87:5153-5157.
15. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
16. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986;78:31-39.
17. Cassis LA, Saye J, Peach MJ. Localization and regulation of rat angiotensinogen messenger RNA. Hypertension. 1988;11:591-596.
18. Klett C, Hellmann W, Hackenthal E, Ganten D. Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin Exp Hypertens. 1993;15:683-708.
19. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987;79:1-6.
20. Gomez RA, Cassis L, Lynch KR, Chevalier RL, Wilfong N, Carey RM, Peach MJ. Fetal expression of the angiotensinogen gene. Endocrinology. 1988;123:2298-2302.
21. Tamura K, Umemura S, Iwamoto T, Yamaguchi S, Kobayashi S, Takeda K, Tokita Y, Takagi N, Murakami K, Fukamizu A. Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension. 1994;23:364-368.
22. McGehee RE Jr, Ron D, Brasier AR, Habener JF. Differentiation-specific element: a cis-acting developmental switch required for the sustained transcriptional expression of the angiotensinogen gene during hormonal-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Mol Endocrinol. 1993;7:551-560.
23. Ron D, Brasier AR, McGehee RE Jr, Habener JF. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). J Clin Invest. 1992;89:223-233.
24. Brasier AR, Philippe J, Campbell DJ, Habener JF. Novel expression of the angiotensinogen gene in a rat pancreatic islet cell line: transcriptional regulation by glucocorticoids. J Biol Chem. 1986;261:16148-16154.
25. Kalinyak JE, Perlman AJ. Tissue-specific regulation of angiotensinogen mRNA accumulation by dexamethasone. J Biol Chem. 1987;262:460-464.
26. Brasier AR, Ron D, Tate JE, Habener JF. Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription. Mol Endocrinol. 1990;4:1921-1933.
27. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem. 1994;48:207-214.
28. Gordon MS, Chin WW, Shupnik MA. Regulation of angiotensinogen gene expression by estrogen. J Hypertens. 1992;10:361-366.
29. Hong-Brown LQ, Deschepper CF. Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells. Endocrinology. 1992;130:1231-1237.
30. Ron D, Brasier AR, Habener JF. Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response. Mol Cell Endocrinol. 1990;74:C97-C104.
31. Ron D, Brasier AR, Wright KA, Tate JE, Habener JF. An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol Cell Biol. 1990;10:1023-1032.
32. Brasier AR, Ron D, Tate JE, Habener JF. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J. 1990;9: 3933-3944.
33. Ron D, Brasier AR, Wright KA, Habener JF. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol. 1990;10:4389-4395.
34. Kageyama R, Ohkubo H, Nakanishi S. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem Biophys Res Commun. 1985;129:826-832.
35. Bouhnik J, Savoie F, Corvol P. Differential effects of inflammation models on rat T-kininogen and rat angiotensinogen. Biochem Pharmacol. 1988;37:1099-1102.
36. Kohara K, Brosnihan KB, Ferrario CM, Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol. 1992;262:E651-E657.
37. Eggena P, Zhu JH, Clegg K, Barrett JD. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension. 1993;22:496-501.
38. Hilgenfeldt U, Schwind S. Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. Am J Physiol. 1993;265:E414-E418.
39. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S, Abe Y. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol. 1990;258:E1-E6.
40. Klett C, Nobiling R, Gierschik P, Hackenthal E. Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J Biol Chem. 1993;268:25095-25107.
41. Shade RE, Davis JO, Johnson JA, Gotshall RW, Spielman WS. Mechanism of action of angiotensin II and antidiuretic hormone on renin secretion. Am J Physiol. 1973;224:926-943.
42. Tjian R, Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell. 1994;77:5-8.
43. Wolffe AP. Transcription: in tune with the histones. Cell. 1994;77: 13-16.
44. Clouston WM, Lyons IG, Richards RI. Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice. EMBO J. 1989;8:3337-3343.
45. Clauser E, Bouhnik J, Jaramillo HN, Auzan C, Corvol P, Menard J. Angiotensinogen production and consumption in the adrenalectomized rat. Endocrinology. 1985;116:247-280.
46. Tanaka T, Ohkubo H, Nakanishi S. Common structural organization of the angiotensinogen and the alpha-1 antitrypsin genes. J Biol Chem. 1984;259:8063-8065.
47. Ohkubo H, Nakayama K, Tanaka T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem. 1986;261:319-323.
48. Clouston WM, Evans LA, Haralambidis J, Richards RI. Molecular cloning of the mouse angiotensinogen gene. Genomics. 1988;2: 240-248.
49. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene. DNA. 1989;8:87-99.
50. Doolittle RF. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science. 1983;222:417-419.
51. Brasier AR, Tate JE, Ron D, Habener JF. Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression. Mol Endocrinol. 1989;3:1022-1034.
52. Ben-Ari ET, Lynch KR, Garrison JC. Glucocorticoids induce the accumulation of novel angiotensinogen gene transcripts. J Biol Chem. 1989;264:13074-13079.
53. Beato M. Gene regulation by steroid hormones. Cell. 1989;56: 335-344.
54. Jantzen HM, Strahle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R, Schutz G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell. 1987;49:29-38.
55. Pratt WB. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem. 1994;268:21445-21458.
56. Archer TK, Lefebvre P, Wolford RG, Hager GL. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science. 1992;255:1573-1576.
57. Pina B, Bruggemeier U, Beato M. Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell. 1990;60:719-731.
58. Hoj Nielsen A, Knudsen F, Angiotensinogen is an acute-phase protein in man. Scand J Clin Lab Invest. 1987;47:175-178.
59. Okamoto H, Hatta A, Itoh N, Ohashi Y, Arakawa K, Nakanishi S. Acute phase responses of plasma angiotensinogen and T-kininogen in rats. Biochem Pharmacol. 1987;36:3069-3073.
60. Takano M, Itoh N, Yayama K, Yamano M, Ohtani R, Okamoto H. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochem Pharmacol. 1993;45:201-206.
61. Brasier AR, Li J, Copland A. Transcription factors modulating angiotensinogen gene expression in hepatocytes. Kidney Int. 1994; 46:1564-1566.
62. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. In press.
63. Baeuerle PA. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072:63-80.
64. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 1991; 12:3805-3817.
65. Ruben SM, Narayanan R, Klement JF, Chen CH, Rosen CA. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol. 1992;12:444-454.
66. Blank V, Kourilsky P, Israel A. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci. 1992;17:135-140.
67. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 1994; 78:773-785.
68. Urban MB, Baeuerle PA. The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. Genes Dev. 1990;4:1975-1984.
69. Baeuerle PA, Baltimore D. A 65-kDa subunit of active NF-kappaB is required for inhibition of NF-κB by IκB. Genes Dev. 1989;3:1689-1698.
70. Beg AA, Baldwin AS Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 1993;7:2064-2070.
71. Tewari M, Dobrzanski P, Mohn KL, Cressman DW, Hsu J-C, Bravo R, Taub R. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol Cell Biol. 1992;12: 2898-2908.
72. Hatada EN, Naumann M, Scheidereit C. Common structural constituents confer IκB activity to NF-κB p105 and IκB/MAD-3. EMBO J. 1993;12:2781-2788.
73. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 1995;267:1485-1488.
74. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 1993;365: 182-185.
75. Lin Y-C, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci U S A. 1995;92:552-556.
76. Naumann M, Scheidereit C. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 1994;13:4597-4607.
77. Ruben SM, Dillon PJ, Schreck R, Henkel T, Chen CH, Maher M, Baeuerle PA, Rosen CA. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science. 1991;251:1490-1493.
78. Kretzschmar M, Meisterernst M, Scheidereit C, Li G, Roeder RG. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev. 1992;6:761-774.
79. Brasier AR, Kumar A. Identification of a novel determinant for basic domain-leucine zipper (bZIP) DNA-binding activity in the acute-phase inducible nuclear factor-interleukin 6 transcription factor. J Biol Chem. 1994;269:10341-10351.
80. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990;9:1897-1906.
81. Nerlov C, Ziff EB. Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. Genes Dev. 1994;8:350-362.
82. Trautwein C, van der Geer P, Karin M, Hunter T, Chojkier M. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. J Clin Invest. 1994;93:2554-2561.
83. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A. 1993;90: 2207-2211.
84. Wegner M, Cao Z, Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science. 1992;256: 370-373.
85. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 1990;4: 1541-1551.
86. Poli V, Mancini FP, Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell. 1990;63:643-653.
87. Chang CJ, Chen T-T, Lei H-Y, Chen D-S, Lee S-C. Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol Cell Biol. 1990;10:6642-6653.
88. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991;5:1538-1552.
89. Williams SC, Cantwell CA, Johnson PF. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 1991;5:1553-1567.
90. Williams SC, Baer M, Dillner AJ, Johnson PF. CRP (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J. 1995; 14:3170-3183.
91. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 1989;3:1146-1156.
92. Isshiki H, Akira S, Sugita T, Nishio Y, Hashimoto S, Pawlowski T, Suematsu S, Kishimoto T. Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: possible involvement of NF-IL6 in acute phase protein gene expression. New Biol. 1991;3:63-70.
93. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 1992;71:765-776.
94. Morishita R, Higaki J, Okunishi H, Tanaka T, Ishii K, Nagano M, Mikami H, Ogihara T, Murakami K, Miyazaki M. Changes in gene expression of the renin-angiotensin system in two kidney, one clip hypertensive rats. J Hypertens. 1991;9:187-192.
95. Gahnem F, Camargo MJ, von Lutterotti N, Laragh JH, Scaly JE. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II. J Hypertens. 1995;13:91-96.
96. Li J, Brasier AR. Angiotensinogen gene activation by Ang II is mediated by the Rel A (NF-κB p65) transcription factor: one mechanism for the renin angiotensin system (RAS) positive feedback loop in hepatocytes. Mol Endocrinol. In press.
97. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
98. Meichle A, Schutze S, Hensel G, Bruming D, Kronke M. Protein kinase C-independent activation of NF-κB by TNF. J Biol Chem. 1990;265:8339-8343.
99. Bouscarel B, Blackmore PF, Exton JH. Characterization of the angiotensin II receptor in primary cultures of rat hepatocytes. J Biol Chem. 1988;263:14913-14919.
100. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in TNF signalling. Cell. 1994;78:1005-1015.
101. Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M. Human 55 kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem. 1992;267: 17997-18001.
102. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem. 1986;261:5901-5906.
103. Lang U, Valloton MB. Angiotensin II but not potassium induces subcellular redistribution of protein kinase C in bovine adrenal glomerulosa cells. J Biol Chem. 1987;262:8047-8050.
104. Sadoshima J-I, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ Res. 1993;73:424-438.
105. Clark AJ, Balla T, Jones MR, Catt KJ. Stimulation of early gene expression by angiotensin II in bovine adrenal glomerulosa cells: roles of calcium and protein kinase C. Mol Endocrinol. 1992;6: 1889-1898.
106. 2+ mobilization and protein kinase C activation. J Biol Chem. 1989;264:526-530.
107. Diaz-Meco MT, Dominguez I, Sanz L, Dent P, Lozano J, Municio MM, Berrn E, Hay RT, Sturgill TW, Moscat J. epsilonPKC induces phosphorylation and inactivation of IκBα in vitro. EMBO J. 1994;13:2842-2848.
108. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375: 247-250.